Business Segment Information (Tables)

12 Months Ended

Dec. 31, 2014

Business Segments

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information
(In millions)			2014		2013		2012
Revenues
	Life Sciences Solutions		$	4,195.7	$	712.5	$	658.8
	Analytical Instruments			3,252.2		3,154.2		3,114.7
	Specialty Diagnostics			3,343.6		3,191.7		2,961.5
	Laboratory Products and Services			6,601.5		6,398.8		6,102.8
	Eliminations			(503.4)		(366.9)		(327.9)
		Consolidated revenues		16,889.6		13,090.3		12,509.9
Segment Income (a)
	Life Sciences Solutions			1,214.9		169.7		154.8
	Analytical Instruments			581.1		558.7		554.6
	Specialty Diagnostics			916.0		863.7		758.1
	Laboratory Products and Services			982.8		960.4		912.4
		Subtotal reportable segments (a)		3,694.8		2,552.5		2,379.9
	Cost of revenues charges			(327.6)		(28.6)		(55.6)
	Selling, general and administrative charges, net			(130.7)		(73.5)		(12.5)
	Restructuring and other (costs) income, net			598.2		(77.7)		(82.1)
	Amortization of acquisition-related intangible assets			(1,331.7)		(763.1)		(747.6)
		Consolidated operating income		2,503.0		1,609.6		1,482.1
	Other expense, net (b)			(415.8)		(290.1)		(212.7)
	Income from continuing operations before income taxes		$	2,087.2	$	1,319.5	$	1,269.4
Depreciation
	Life Sciences Solutions		$	131.6	$	17.1	$	16.8
	Analytical Instruments			39.0		41.2		42.5
	Specialty Diagnostics			76.7		73.9		72.9
	Laboratory Products and Services			105.8		104.6		103.9
		Consolidated depreciation	$	353.1	$	236.8	$	236.1
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

(In millions)			2014		2013		2012
Total Assets
	Life Sciences Solutions		$	19,257.0	$	1,115.5	$	1,115.6
	Analytical Instruments			4,133.3		4,321.4		4,304.9
	Specialty Diagnostics			8,047.7		9,086.0		9,841.0
	Laboratory Products and Services			10,875.7		11,523.5		11,531.5
	Corporate/Other (c)			538.4		5,817.0		651.6
		Consolidated total assets	$	42,852.1	$	31,863.4	$	27,444.6
Capital Expenditures
	Life Sciences Solutions		$	104.4	$	19.3	$	26.9
	Analytical Instruments			38.1		33.5		42.0
	Specialty Diagnostics			84.7		77.9		97.6
	Laboratory Products and Services			102.1		94.7		112.6
	Corporate/Other			98.3		57.0		36.0
		Consolidated capital expenditures	$	427.6	$	282.4	$	315.1
(c)	Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices and assets of the discontinued operations.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information
(In millions)			2014		2013		2012
Revenues
	Life Sciences Solutions		$	4,195.7	$	712.5	$	658.8
	Analytical Instruments			3,252.2		3,154.2		3,114.7
	Specialty Diagnostics			3,343.6		3,191.7		2,961.5
	Laboratory Products and Services			6,601.5		6,398.8		6,102.8
	Eliminations			(503.4)		(366.9)		(327.9)
		Consolidated revenues		16,889.6		13,090.3		12,509.9
Segment Income (a)
	Life Sciences Solutions			1,214.9		169.7		154.8
	Analytical Instruments			581.1		558.7		554.6
	Specialty Diagnostics			916.0		863.7		758.1
	Laboratory Products and Services			982.8		960.4		912.4
		Subtotal reportable segments (a)		3,694.8		2,552.5		2,379.9
	Cost of revenues charges			(327.6)		(28.6)		(55.6)
	Selling, general and administrative charges, net			(130.7)		(73.5)		(12.5)
	Restructuring and other (costs) income, net			598.2		(77.7)		(82.1)
	Amortization of acquisition-related intangible assets			(1,331.7)		(763.1)		(747.6)
		Consolidated operating income		2,503.0		1,609.6		1,482.1
	Other expense, net (b)			(415.8)		(290.1)		(212.7)
	Income from continuing operations before income taxes		$	2,087.2	$	1,319.5	$	1,269.4
Depreciation
	Life Sciences Solutions		$	131.6	$	17.1	$	16.8
	Analytical Instruments			39.0		41.2		42.5
	Specialty Diagnostics			76.7		73.9		72.9
	Laboratory Products and Services			105.8		104.6		103.9
		Consolidated depreciation	$	353.1	$	236.8	$	236.1
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

(In millions)			2014		2013		2012
Revenues (d)
	United States		$	8,147.7	$	6,617.0	$	6,424.4
	China			1,223.1		896.6		735.8
	Germany			1,005.9		758.6		681.5
	United Kingdom			754.5		532.4		507.1
	Other			5,758.4		4,285.7		4,161.1
		Consolidated revenues	$	16,889.6	$	13,090.3	$	12,509.9
Long-lived Assets (e)
	United States		$	1,501.7	$	892.9	$	862.4
	United Kingdom			265.5		224.3		223.9
	Germany			170.3		165.9		165.2
	Other			489.0		484.3		474.9
		Consolidated long-lived assets	$	2,426.5	$	1,767.4	$	1,726.4
(d)	Revenues are attributed to countries based on customer location.
(e)	Includes property, plant and equipment, net.